Literature DB >> 35997896

Family Spillover Effects: Are Economic Evaluations Misrepresenting the Value of Healthcare Interventions to Society?

Ashley A Leech1,2, Pei-Jung Lin3, Brittany D'Cruz3, Susan K Parsons4,5, Tara A Lavelle3.   

Abstract

The societal impacts of health interventions are seldom incorporated into health economic evaluations, including the impact that illness can have on informal or unpaid caregivers and other family members (i.e., "family spillover effects"). Previous research has demonstrated that by excluding family spillover effects, the value of health interventions may be underestimated on average. In this commentary, we discuss how the inclusion of spillover effects influences how we value interventions and, given the extent to which caregiver/family effects are largely not captured or known, propose ways in which these data could be more systematically collected or estimated and used by researchers. These recommendations include prioritizing data collection alongside clinical trials and patient registries, engaging expert opinion panels, and developing mapping algorithms for estimating caregiver/family utility values from non-preference-based caregiver health-related quality-of-life measures and/or from patient preference-based measures.
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Year:  2022        PMID: 35997896     DOI: 10.1007/s40258-022-00755-8

Source DB:  PubMed          Journal:  Appl Health Econ Health Policy        ISSN: 1175-5652            Impact factor:   3.686


  50 in total

Review 1.  Does including informal care in economic evaluations matter? A systematic review of inclusion and impact of informal care in cost-effectiveness studies.

Authors:  Marieke Krol; Jocé Papenburg; Job van Exel
Journal:  Pharmacoeconomics       Date:  2015-02       Impact factor: 4.981

2.  Setting value-based payment goals--HHS efforts to improve U.S. health care.

Authors:  Sylvia M Burwell
Journal:  N Engl J Med       Date:  2015-01-26       Impact factor: 91.245

Review 3.  Family Caregiving in Serious Illness in the United States: Recommendations to Support an Invisible Workforce.

Authors:  Janice F Bell; Robin L Whitney; Heather M Young
Journal:  J Am Geriatr Soc       Date:  2019-05       Impact factor: 5.562

4.  The opportunity costs of informal elder-care in the United States: new estimates from the American Time Use Survey.

Authors:  Amalavoyal V Chari; John Engberg; Kristin N Ray; Ateev Mehrotra
Journal:  Health Serv Res       Date:  2014-10-07       Impact factor: 3.402

5.  Caring for and caring about: disentangling the caregiver effect and the family effect.

Authors:  Ana Bobinac; N Job A van Exel; Frans F H Rutten; Werner B F Brouwer
Journal:  J Health Econ       Date:  2010-06-01       Impact factor: 3.883

6.  Health as a Family Affair.

Authors:  Eve Wittenberg; Lisa A Prosser
Journal:  N Engl J Med       Date:  2016-05-12       Impact factor: 91.245

7.  Use of Decision Models in the Development of Evidence-Based Clinical Preventive Services Recommendations: Methods of the U.S. Preventive Services Task Force.

Authors:  Douglas K Owens; Evelyn P Whitlock; Jillian Henderson; Michael P Pignone; Alex H Krist; Kirsten Bibbins-Domingo; Susan J Curry; Karina W Davidson; Mark Ebell; Matthew W Gillman; David C Grossman; Alex R Kemper; Ann E Kurth; Michael Maciosek; Albert L Siu; Michael L LeFevre
Journal:  Ann Intern Med       Date:  2016-07-05       Impact factor: 25.391

8.  An Overview of Value, Perspective, and Decision Context-A Health Economics Approach: An ISPOR Special Task Force Report [2].

Authors:  Louis P Garrison; Mark V Pauly; Richard J Willke; Peter J Neumann
Journal:  Value Health       Date:  2018-02       Impact factor: 5.725

Review 9.  Frequency and impact of the inclusion of broader measures of value in economic evaluations of vaccines.

Authors:  Madison C Silver; Peter J Neumann; Siyu Ma; David D Kim; Joshua T Cohen; Mawuli Nyaku; Craig Roberts; Anushua Sinha; Daniel A Ollendorf
Journal:  Vaccine       Date:  2021-10-14       Impact factor: 3.641

10.  Perspective and Costing in Cost-Effectiveness Analysis, 1974-2018.

Authors:  David D Kim; Madison C Silver; Natalia Kunst; Joshua T Cohen; Daniel A Ollendorf; Peter J Neumann
Journal:  Pharmacoeconomics       Date:  2020-10       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.